Vethanayagam J G, Green E H, Rose R C, Bode A M
Department of Physiology, University of North Dakota School of Medicine and Health Sciences, Grand Forks.
Free Radic Biol Med. 1999 Jun;26(11-12):1591-8. doi: 10.1016/s0891-5849(99)00031-3.
An efficient regeneration of vitamin C (ascorbate) from its oxidized byproduct, dehydroascorbate (DHAA), is necessary to maintain sufficient tissue levels of the reduced form of the vitamin. Additionally, the recycling may be more significant in mammals, such as guinea pigs and humans, who have lost the ability to synthesize ascorbate de novo, than it is in most other mammals who have retained the ability to synthesize the vitamin from glucose. Both a chemical and an enzymatic reduction of DHAA to ascorbate have been proposed. Several reports have appeared in which proteins, including thioltransferase, protein disulfide isomerase, and 3-alpha-hydroxysteroid dehydrogenase, characterized for other activities have been identified as having DHAA reductase activity in vitro. Whether these previously characterized proteins catalyze the reduction of DHAA in vivo is unclear. In the present study, a 66 kD protein was purified strictly on the basis of its DHAA-reductase activity and was identified as rat serum albumin. The protein was further characterized and results support the suggestion that serum albumin acts as an antioxidant and exerts a significant glutathione-dependent DHAA-reductase activity that may be important in the physiologic recycling of ascorbic acid.
从其氧化副产物脱氢抗坏血酸(DHAA)高效再生维生素C(抗坏血酸盐)对于维持该维生素还原形式在组织中的充足水平是必要的。此外,这种循环在豚鼠和人类等已失去从头合成抗坏血酸盐能力的哺乳动物中可能比在大多数其他仍保留从葡萄糖合成该维生素能力的哺乳动物中更为重要。已提出了将DHAA化学还原和酶促还原为抗坏血酸的方法。有几份报告指出,包括硫醇转移酶、蛋白质二硫键异构酶和3-α-羟基类固醇脱氢酶在内的一些蛋白质,因其其他活性而被表征,已被鉴定在体外具有DHAA还原酶活性。这些先前表征的蛋白质是否在体内催化DHAA的还原尚不清楚。在本研究中,一种66 kD的蛋白质严格基于其DHAA还原酶活性进行纯化,并被鉴定为大鼠血清白蛋白。对该蛋白质进行了进一步表征,结果支持血清白蛋白作为抗氧化剂发挥作用并具有显著的依赖谷胱甘肽的DHAA还原酶活性这一观点,该活性可能在抗坏血酸的生理循环中很重要。